Immediate Impact

3 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Structure–function coupling in macroscale human brain networks
2024 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
2 intermediate papers

Works of Robert Clafferty being referenced

Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia
2001
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study
2000

Author Peers

Author Last Decade Papers Cites
Robert Clafferty 365 126 49 149 11 505
M. Jackuelyn Harris 369 69 59 98 10 539
Annie M. Bollini 283 98 21 192 13 558
Piotr J. Quee 396 116 41 153 15 512
Frank Fleming 201 106 22 189 9 492
Evelyn Bromet 393 140 34 116 10 542
Joëlle A. Pasman 277 63 52 215 24 573
Stanley Mutsatsa 454 126 96 136 16 564
Gerald Goldstein 280 234 20 162 12 509
Peretz Barak 255 52 22 144 10 483
Graham Bean 194 88 14 173 17 460

All Works

Loading papers...

Rankless by CCL
2026